Biodesix, Inc. BDSX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$7.79M-95.8% | -$3.98M+54.3% | -$8.72M+24.0% | -$11.47M-3.3% | -$11.1M-34.5% | ||
| $1.4M+0.6% | $1.39M-1.4% | $1.41M-2.1% | $1.44M-0.3% | $1.44M-0.6% | ||
| $1.12M+3.7% | $1.08M+2.1% | $1.05M+1.3% | $1.04M+6.9% | $972K-23.2% | ||
| $24K-66.2% | $71K— | $0-100% | $8K-92.1% | $101K-76.7% | ||
| $488K— | —— | $5.22M+2,986% | -$181K+80.0% | -$904K-190% | ||
| -$2.34M-341% | $974K+100% | $486K-79.2% | $2.34M+221% | -$1.94M-214% | ||
| -$19K— | $0-100% | $125K+525% | $20K+233% | -$15K+21.1% | ||
| -$766K— | —— | $2.13M+1,180% | -$197K-337% | $83K— | ||
| $5K+400% | $1K-85.7% | $7K-73.1% | $26K-64.4% | $73K-29.1% | ||
| -$341K-8.3% | -$315K-40.6% | -$224K+3.4% | -$232K-1,189% | -$18K-155% | ||
| $1.37M+131% | $592K+3,800% | -$16K+84.5% | -$103K+52.1% | -$215K— | ||
| -$10.17M— | $0+100% | -$8.88M-35.2% | -$6.57M+23.6% | -$8.6M-110% | ||
| $81K-5.8% | $86K+79.2% | $48K-5.9% | $51K-31.1% | $74K-91.2% | ||
| -$144K-38.5% | -$104K-55.2% | -$67K+29.5% | -$95K+30.7% | -$137K+84.5% | ||
| $5K0.0% | $5K+25.0% | $4K-20.0% | $5K-28.6% | $7K-46.2% | ||
| $17.21M+642% | $2.32M— | —— | —— | —— | ||
| -$158K+39.7% | -$262K-56.9% | -$167K+12.1% | -$190K+4.0% | -$198K-17.2% | ||
| $28K— | $0-100% | $3K-81.3% | $16K+45.5% | $11K+83.3% | ||
| $16.9M+889% | $1.71M-64.6% | $4.82M-50.7% | $9.79M+9,992% | $97K— | ||
| $6.59M— | —— | -$4.12M— | —— | -$8.64M-67.4% | ||
| $1.62M-5.2% | $1.71M-1.9% | $1.75M+11.7% | $1.56M+13.3% | $1.38M-46.6% | ||
| $332K-0.3% | $333K+0.3% | $332K+0.6% | $330K+6.8% | $309K+4.7% | ||
| -$341K-8.3% | -$315K-40.6% | -$224K+3.4% | -$232K-1,189% | -$18K-155% | ||
| $1.37M+131% | $592K+3,800% | -$16K+84.5% | -$103K+52.1% | -$215K— | ||
| $20K-28.6% | $28K+180% | $10K— | —— | —— | ||
| $19K— | —— | —— | —— | -$35K— | ||
| $24K-66.2% | $71K— | $0-100% | $8K-92.1% | $101K-76.7% | ||
| $63K+250% | $18K-5.3% | $19K-56.8% | $44K-30.2% | $63K+40.0% | ||
| $481K+39.8% | $344K— | —— | —— | —— | ||
| $28K— | $0-100% | $3K-81.3% | $16K+45.5% | $11K+83.3% | ||
| $354K— | —— | $184K— | —— | $313K+31,200% | ||
| -$158K+39.7% | -$262K-56.9% | -$167K+12.1% | -$190K+4.0% | -$198K-17.2% | ||
| —— | —— | —— | $200K-47.1% | $378K— | ||
| -$766K— | —— | $2.13M+1,180% | -$197K-337% | $83K— | ||
| -$341K-8.3% | -$315K-40.6% | -$224K+3.4% | -$232K-1,189% | -$18K-155% | ||
| —— | $859K+107% | $414K— | $0-100% | $172K-64.5% | ||
| $59K— | —— | $687K— | —— | $45K-85.1% | ||
| —— | —— | —— | —— | $8K— | ||
| $64K+3,557% | $1.75K0.0% | $1.75K0.0% | $1.75K0.0% | $1.75K— | ||
| $1.25M— | —— | —— | —— | —— | ||
| -$10.25M— | $0+100% | -$8.93M-34.9% | -$6.62M+23.7% | -$8.68M-75.8% | ||
| -$10.25M— | $0+100% | -$8.93M-34.9% | -$6.62M+23.7% | -$8.68M-75.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Biodesix, Inc. generate?
- Biodesix, Inc. (BDSX) generated -$25.6M in operating cash flow over the trailing twelve months.
- What is Biodesix, Inc.'s free cash flow?
- After $266.0K of capital expenditures, Biodesix, Inc.'s free cash flow was -$25.8M over the trailing twelve months, up 42.7% year over year.
- Where does Biodesix, Inc.'s cash flow data come from?
- Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
